The Food and Drug Administration has issued a new warning about popular sleep drugs now that studies show they don't leave your system as soon as earlier believed. New data, using driving simulators and blood tests, show sleep drugs like Ambien, Ambien CR, Edluar, and Zolpimist can still be active the morning after use, and driving could be impaired. Women appear to be particularly affected because they metabolize the drug slower than men. Experts are recommending the dose be cut in half for women, and men should consider using a lower dose. They say this will ensure less of the drug is present in the blood in the morning. FDA officials say patients should not change the dose on their own, but rather they should talk to their doctor first.
Copyright 2013 KCBD. All rights reserved.